These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 5309470)
21. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination. Muhamed G; Greenbaum E; Zakay-Rones Z Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048 [TBL] [Abstract][Full Text] [Related]
22. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis]. Mukhina LP; Bichurina MA; Rozaeva NR Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508 [No Abstract] [Full Text] [Related]
23. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia. Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232 [TBL] [Abstract][Full Text] [Related]
24. The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice. Cox RJ; Hovden AO; Brokstad KA; Szyszko E; Madhun AS; Haaheim LR Vaccine; 2006 Nov; 24(44-46):6585-7. PubMed ID: 16839650 [TBL] [Abstract][Full Text] [Related]
25. Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine. Kasel JA; Hume EB; Fulk RV; Togo Y; Huber M; Hornick RB J Immunol; 1969 Mar; 102(3):555-62. PubMed ID: 5773312 [No Abstract] [Full Text] [Related]
26. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial. Cools HJ; Gussekloo J; Remmerswaal JE; Remarque EJ; Kroes AC J Med Virol; 2009 May; 81(5):908-14. PubMed ID: 19319953 [TBL] [Abstract][Full Text] [Related]
27. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model. Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of intradermally administered A2 Hong Kong vaccine. Foy HM; Sealey L; Cooney MK; Bor E JAMA; 1970 Jul; 213(1):130. PubMed ID: 5467968 [No Abstract] [Full Text] [Related]
34. Antibody response to inactivated influenza vaccine given by different routes in patients with chronic bronchopulmonary disease. Shore SL; Potter CW; Stuart-Harris CH Thorax; 1973 Nov; 28(6):721-8. PubMed ID: 4787984 [No Abstract] [Full Text] [Related]
35. Antibody response in man to two doses of polyvalent influenza virus vaccine. WARBURTON MF; DUXBURY AE; GREVILLE RW Med J Aust; 1959 Jun; 1(24):786-90. PubMed ID: 13666175 [No Abstract] [Full Text] [Related]